Skip to content

Noninvasive Positive Pressure Ventilation in Overlap Syndrome

The Effectiveness of Noninvasive Positive Pressure Ventilation Treatment in Overlap Syndrome

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03184714
Enrollment
292
Registered
2017-06-14
Start date
2017-06-15
Completion date
2020-12-31
Last updated
2017-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Non-invasive Positive Pressure Ventilation, Sleep Apnea Syndromes

Brief summary

Chronic obstructive pulmonary diseases (COPD) coexisting with obstructive sleep apnea is called overlap syndrome (OS). Patients with OS seem to have worse prognosis than patients with only one disorder. Noninvasive positive pressure ventilation is an efficient treatment in obstructive sleep apnea, but the effectiveness in improving outcomes of OS patients is still not fully investigated. The aim of this non-randomized concurrent control trial is to evaluate noninvasive positive pressure ventilation's effectiveness in OS patients.

Interventions

DEVICENIPPV

BiPAP treatment for 3 years

Sponsors

Chinese Academy of Medical Sciences, Fuwai Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

non-invasive positive pressure ventilation

Eligibility

Sex/Gender
ALL
Age
40 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* patients with COPD and sleep apnea dyspnea syndrome

Exclusion criteria

* patients with non-stable hemodynamics; * patients with limited life expectancy; * patients with other severe respiratory diseases; * patients with motor neuron diseases; * patients with contraindications for NIPPV

Design outcomes

Primary

MeasureTime frameDescription
COPD acute exacerbations3 yearstotal times of COPD acute exacerbations

Secondary

MeasureTime frameDescription
COPD assessment test (CAT) score3 yearssymptom score of COPD
modified British medical research council (mMRC) score3 yearsdyspnea score
all-cause mortality3 yearssurvival rate in %

Countries

China

Contacts

Primary ContactKe Hu, MD
hukejx@163.com18971035988

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026